Connection

Guido Grassi to Humans

This is a "connection" page, showing publications Guido Grassi has written about Humans.
Connection Strength

0.428
  1. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy? Pharmacol Res. 2020 08; 158:104906.
    View in: PubMed
    Score: 0.007
  2. Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev. 2020 Apr; 27(2):105-108.
    View in: PubMed
    Score: 0.007
  3. Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis. J Hypertens. 2019 09; 37(9):1746-1756.
    View in: PubMed
    Score: 0.007
  4. Sympathetic Nerve Traffic and Arterial Baroreflex Function in Apparent Drug-Resistant Hypertension. Hypertension. 2019 10; 74(4):903-909.
    View in: PubMed
    Score: 0.007
  5. Resistant Hypertension Management: Comparison of the 2017 American and 2018 European High Blood Pressure Guidelines. Curr Hypertens Rep. 2019 07 18; 21(9):67.
    View in: PubMed
    Score: 0.007
  6. Sympathetic Neural Overdrive in the Obese and Overweight State. Hypertension. 2019 08; 74(2):349-358.
    View in: PubMed
    Score: 0.007
  7. Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 2019 04; 37(4):844-850.
    View in: PubMed
    Score: 0.007
  8. Intriguing relationship between antihypertensive therapy and cancer. Pharmacol Res. 2019 03; 141:501-511.
    View in: PubMed
    Score: 0.006
  9. Masked Uncontrolled Hypertension. Hypertension. 2019 01; 73(1):39-41.
    View in: PubMed
    Score: 0.006
  10. Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study. J Clin Hypertens (Greenwich). 2019 01; 21(1):39-45.
    View in: PubMed
    Score: 0.006
  11. The European Society of Cardiology (ESC)/European Society of Hypertension (ESH) 2018 guidelines for hypertension diagnosis and treatment: New concepts and recommendations. Pharmacol Res. 2019 01; 139:489-490.
    View in: PubMed
    Score: 0.006
  12. The role of arterial hypertension in development heart failure with preserved ejection fraction: just a risk factor or something more? Heart Fail Rev. 2018 09; 23(5):631-639.
    View in: PubMed
    Score: 0.006
  13. Big Data and Blood Pressure Control: Insights from the PAMELA and BP-CARE Study Cohorts. Curr Hypertens Rep. 2018 07 26; 20(10):82.
    View in: PubMed
    Score: 0.006
  14. Sympathetic Nervous System, Sleep, and Hypertension. Curr Hypertens Rep. 2018 07 06; 20(9):74.
    View in: PubMed
    Score: 0.006
  15. Uric acid and risk of new-onset metabolic syndrome, impaired fasting glucose and diabetes mellitus in a general Italian population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study. J Hypertens. 2018 07; 36(7):1492-1498.
    View in: PubMed
    Score: 0.006
  16. The norepinephrine transporter deserves more attention. J Hypertens. 2018 07; 36(7):1472-1474.
    View in: PubMed
    Score: 0.006
  17. Monographic issue of pharmacological research on hypertension. Pharmacol Res. 2018 08; 134:221-222.
    View in: PubMed
    Score: 0.006
  18. Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses. Hypertension. 2018 08; 72(2):483-491.
    View in: PubMed
    Score: 0.006
  19. Metoprolol in the treatment of cardiovascular disease: a critical reappraisal. Curr Med Res Opin. 2018 09; 34(9):1635-1643.
    View in: PubMed
    Score: 0.006
  20. Vascular aging and target organ damage: is it predictable? J Hypertens. 2018 06; 36(6):1269-1271.
    View in: PubMed
    Score: 0.006
  21. Sympathetic and baroreflex abnormalities in the uncomplicated prediabetic state. J Hypertens. 2018 05; 36(5):1195-1200.
    View in: PubMed
    Score: 0.006
  22. Albuminuria and diabetes: a question of eye and skin points of view. J Hypertens. 2018 05; 36(5):1036-1037.
    View in: PubMed
    Score: 0.006
  23. The importance of pulse pressure on cardiovascular risk and total mortality in the general population: Is sex relevant? J Clin Hypertens (Greenwich). 2018 06; 20(6):1001-1007.
    View in: PubMed
    Score: 0.006
  24. Hypertensive heart disease beyond left ventricular hypertrophy: are we ready for echocardiographic strain evaluation in everyday clinical practice? J Hypertens. 2018 04; 36(4):744-753.
    View in: PubMed
    Score: 0.006
  25. Refractory hypertension focus on nighttime blood pressure and nondipping. J Clin Hypertens (Greenwich). 2018 03; 20(3):447-449.
    View in: PubMed
    Score: 0.006
  26. Heart rate as a predictor of cardiovascular risk. Eur J Clin Invest. 2018 Mar; 48(3).
    View in: PubMed
    Score: 0.006
  27. Pharmacological intervention in hypertension using beta-blockers: Real-world evidence for long-term effectiveness. Pharmacol Res. 2018 04; 130:191-197.
    View in: PubMed
    Score: 0.006
  28. Right heart remodeling induced by arterial hypertension: Could strain assessment be helpful? J Clin Hypertens (Greenwich). 2018 02; 20(2):400-407.
    View in: PubMed
    Score: 0.006
  29. Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach. Diabetologia. 2018 Mar; 61(3):517-525.
    View in: PubMed
    Score: 0.006
  30. Association Between Atrial, Ventricular and Vascular Morphofunctional Alterations in Rheumatoid Arthritis. High Blood Press Cardiovasc Prev. 2018 Mar; 25(1):97-104.
    View in: PubMed
    Score: 0.006
  31. 'Keep an eye' on the heart: retinal microcirculation disarray in congestive heart failure. Eur Heart J. 2018 01 01; 39(1):57-59.
    View in: PubMed
    Score: 0.006
  32. Restoration of normal sympathetic neural function in heart failure following baroreflex activation therapy: final 43-month study report. J Hypertens. 2017 12; 35(12):2532-2536.
    View in: PubMed
    Score: 0.006
  33. True versus pseudoresistant hypertension. J Hypertens. 2017 12; 35(12):2367-2368.
    View in: PubMed
    Score: 0.006
  34. Home blood pressure measurement in the frail elderly: does it matter? J Hypertens. 2017 12; 35(12):2374-2376.
    View in: PubMed
    Score: 0.006
  35. Effects of serum uric acid on blood-pressure lowering treatment. Curr Med Res Opin. 2017 11; 33(sup3):15-19.
    View in: PubMed
    Score: 0.006
  36. Short-term blood pressure variability in acute coronary syndrome. J Clin Hypertens (Greenwich). 2017 12; 19(12):1249-1251.
    View in: PubMed
    Score: 0.006
  37. Glucose intolerance as the key risk factor for metabolic syndrome. J Clin Hypertens (Greenwich). 2017 09; 19(9):848-849.
    View in: PubMed
    Score: 0.006
  38. Cardiovascular Risk Associated With White-Coat Hypertension: Pro Side of the Argument. Hypertension. 2017 10; 70(4):668-675.
    View in: PubMed
    Score: 0.006
  39. Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome. J Hypertens. 2017 08; 35(8):1685-1690.
    View in: PubMed
    Score: 0.006
  40. Retinal microvascular diameters: normative data and their use in clinical hypertension. J Hypertens. 2017 08; 35(8):1573-1574.
    View in: PubMed
    Score: 0.006
  41. Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients. High Blood Press Cardiovasc Prev. 2017 Dec; 24(4):393-400.
    View in: PubMed
    Score: 0.006
  42. Does a blood pressure J curve exist for patients with chronic kidney disease? J Clin Hypertens (Greenwich). 2017 Aug; 19(8):764-770.
    View in: PubMed
    Score: 0.006
  43. Quarter Dose Combination Therapy: Good News for Blood Pressure Control. Hypertension. 2017 07; 70(1):32-34.
    View in: PubMed
    Score: 0.006
  44. Obesity and hypertension. Pharmacol Res. 2017 Aug; 122:1-7.
    View in: PubMed
    Score: 0.006
  45. Hypertension: Quarter dose quadpill combinations: a new therapeutic approach. Nat Rev Nephrol. 2017 05; 13(5):266-267.
    View in: PubMed
    Score: 0.006
  46. Hypertension and hepatic triglycerides content: a two (multi)-faceted clinical challenge? J Hypertens. 2017 04; 35(4):715-717.
    View in: PubMed
    Score: 0.006
  47. Prognostic significance of masked tachycardia in hypertension: evidence from a prospective international registry. J Hypertens. 2017 03; 35(3):468-470.
    View in: PubMed
    Score: 0.006
  48. Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report. Medicine (Baltimore). 2017 Mar; 96(13):e6024.
    View in: PubMed
    Score: 0.006
  49. Heart and kidneys: separate targets of carotid and aortic stiffness? J Hypertens. 2017 02; 35(2):243-245.
    View in: PubMed
    Score: 0.006
  50. Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study. Adv Ther. 2017 01; 33(12):2173-2187.
    View in: PubMed
    Score: 0.006
  51. Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients. Hypertension. 2014 Aug; 64(2):431-7.
    View in: PubMed
    Score: 0.005
  52. Left-ventricular hypertrophy and obesity: a systematic review and meta-analysis of echocardiographic studies. J Hypertens. 2014 Jan; 32(1):16-25.
    View in: PubMed
    Score: 0.005
  53. Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep. 2012 Aug; 14(4):333-8.
    View in: PubMed
    Score: 0.004
  54. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation. Can J Cardiol. 2012 May; 28(3):311-7.
    View in: PubMed
    Score: 0.004
  55. Diurnal blood pressure variation and sympathetic activity. Hypertens Res. 2010 May; 33(5):381-5.
    View in: PubMed
    Score: 0.003
  56. Heart rate as a sympathetic marker during acute adrenergic challenge. J Hypertens. 2008 Jan; 26(1):70-5.
    View in: PubMed
    Score: 0.003
  57. Assessment of retinal vascular changes in hypertension: new perspectives. J Hypertens. 2006 May; 24(5):813-4.
    View in: PubMed
    Score: 0.003
  58. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension. 2005 Aug; 46(2):321-5.
    View in: PubMed
    Score: 0.003
  59. Coronavirus disease 2019 and cardiovascular complications: focused clinical review. J Hypertens. 2021 07 01; 39(7):1282-1292.
    View in: PubMed
    Score: 0.002
  60. Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic. J Hypertens. 2021 06 01; 39(6):1077-1089.
    View in: PubMed
    Score: 0.002
  61. Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension. J Hypertens. 2021 02 01; 39(2):376-380.
    View in: PubMed
    Score: 0.002
  62. Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev. 2021 Jan; 28(1):5-11.
    View in: PubMed
    Score: 0.002
  63. Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension. PLoS One. 2020; 15(10):e0237297.
    View in: PubMed
    Score: 0.002
  64. COVID-19 and arterial hypertension: Hypothesis or evidence? J Clin Hypertens (Greenwich). 2020 07; 22(7):1120-1126.
    View in: PubMed
    Score: 0.002
  65. Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020 08; 76(2):366-372.
    View in: PubMed
    Score: 0.002
  66. Extreme dipping: is the cardiovascular risk increased? An unsolved issue. J Hypertens. 2019 10; 37(10):1917-1926.
    View in: PubMed
    Score: 0.002
  67. The relationship between functional capacity and left ventricular strain in patients with uncomplicated type 2 diabetes. J Hypertens. 2019 09; 37(9):1871-1876.
    View in: PubMed
    Score: 0.002
  68. Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension. J Hypertens. 2019 08; 37(8):1541-1546.
    View in: PubMed
    Score: 0.002
  69. High-normal blood pressure and abnormal left ventricular geometric patterns: a meta-analysis. J Hypertens. 2019 07; 37(7):1312-1319.
    View in: PubMed
    Score: 0.002
  70. Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid. J Clin Hypertens (Greenwich). 2019 07; 21(7):975-983.
    View in: PubMed
    Score: 0.002
  71. Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review. J Am Coll Cardiol. 2019 06 18; 73(23):3006-3017.
    View in: PubMed
    Score: 0.002
  72. The global burden of hypertension exceeds 1.4 billion people: should a systolic blood pressure target below 130 become the universal standard? J Hypertens. 2019 06; 37(6):1148-1153.
    View in: PubMed
    Score: 0.002
  73. Incident Left Ventricular Hypertrophy in Masked Hypertension. Hypertension. 2019 07; 74(1):56-62.
    View in: PubMed
    Score: 0.002
  74. Exploring the interplay between job strain and different domains of physical activity on the incidence of coronary heart disease in adult men. Eur J Prev Cardiol. 2019 11; 26(17):1877-1885.
    View in: PubMed
    Score: 0.002
  75. Left atrial phasic function in hypertensive patients with significant aortic stenosis and preserved ejection fraction. Hypertens Res. 2019 08; 42(8):1200-1208.
    View in: PubMed
    Score: 0.002
  76. The impact of arterial hypertension on left ventricular strain in patients with aortic stenosis and preserved ejection fraction. J Hypertens. 2019 04; 37(4):747-753.
    View in: PubMed
    Score: 0.002
  77. Left atrial volume in elite athletes: A meta-analysis of echocardiographic studies. Scand J Med Sci Sports. 2019 Jul; 29(7):922-932.
    View in: PubMed
    Score: 0.002
  78. Right ventricular mechanics in patients with aortic stenosis and preserved ejection fraction: Is arterial hypertension a new player in the game? J Clin Hypertens (Greenwich). 2019 04; 21(4):516-523.
    View in: PubMed
    Score: 0.002
  79. High Normal Blood Pressure and Left Ventricular Hypertrophy Echocardiographic Findings From the PAMELA Population. Hypertension. 2019 03; 73(3):612-619.
    View in: PubMed
    Score: 0.002
  80. Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report. BMC Infect Dis. 2019 Jan 09; 19(1):34.
    View in: PubMed
    Score: 0.002
  81. Gender-specific therapeutic approach in arterial hypertension - Challenges ahead. Pharmacol Res. 2019 03; 141:181-188.
    View in: PubMed
    Score: 0.002
  82. Response to: Gender differences and the association between right ventricular strain and arterial hypertension-A commentary. J Clin Hypertens (Greenwich). 2019 01; 21(1):139-140.
    View in: PubMed
    Score: 0.002
  83. Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report. J Med Case Rep. 2018 Oct 03; 12(1):296.
    View in: PubMed
    Score: 0.002
  84. Pre-hypertension and subclinical carotid damage: a meta-analysis. J Hum Hypertens. 2019 01; 33(1):34-40.
    View in: PubMed
    Score: 0.002
  85. Risk of new-onset metabolic syndrome associated with white-coat and masked hypertension: data from a general population. J Hypertens. 2018 09; 36(9):1833-1839.
    View in: PubMed
    Score: 0.002
  86. Does gender affect the association between right ventricular strain and arterial hypertension? J Clin Hypertens (Greenwich). 2018 09; 20(9):1327-1333.
    View in: PubMed
    Score: 0.002
  87. Pre-hypertension and subclinical cardiac damage: A meta-analysis of echocardiographic studies. Int J Cardiol. 2018 Nov 01; 270:302-308.
    View in: PubMed
    Score: 0.002
  88. Night-time heart rate nondipping: clinical and prognostic significance in the general population. J Hypertens. 2018 06; 36(6):1311-1317.
    View in: PubMed
    Score: 0.002
  89. Isolated systolic hypertension in the young: a position paper endorsed by the European Society of Hypertension. J Hypertens. 2018 06; 36(6):1222-1236.
    View in: PubMed
    Score: 0.002
  90. Cardiovascular disease prevention at the workplace: assessing the prognostic value of lifestyle risk factors and job-related conditions. Int J Public Health. 2018 Jul; 63(6):723-732.
    View in: PubMed
    Score: 0.002
  91. Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS) : Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH). Clin Auton Res. 2018 08; 28(4):355-362.
    View in: PubMed
    Score: 0.002
  92. Sympathetic baroreceptor regulation during hypoxic hypotension in humans: new insights. J Hypertens. 2018 05; 36(5):1188-1194.
    View in: PubMed
    Score: 0.002
  93. In Memoriam: Alberto Zanchetti (Parma July 27, 1926 - Milan March 24, 2018). J Clin Hypertens (Greenwich). 2018 05; 20(5):826-828.
    View in: PubMed
    Score: 0.002
  94. Age- and Sex-Specific Reference Values for Media/Lumen Ratio in Small Arteries and Relationship With Risk Factors. Hypertension. 2018 06; 71(6):1193-1200.
    View in: PubMed
    Score: 0.002
  95. In healthy normotensive subjects age and blood pressure better predict subclinical vascular and cardiac organ damage than atherosclerosis biomarkers. Blood Press. 2018 10; 27(5):262-270.
    View in: PubMed
    Score: 0.002
  96. Differing associations for sport versus occupational physical activity and cardiovascular risk. Heart. 2018 07; 104(14):1165-1172.
    View in: PubMed
    Score: 0.002
  97. Carotid intima-media thickness and anti-hypertensive treatment: Focus on angiotensin II receptor blockers. Pharmacol Res. 2018 03; 129:20-26.
    View in: PubMed
    Score: 0.002
  98. Metabolic syndrome and subclinical carotid damage: a meta-analysis from population-based studies. J Hypertens. 2018 01; 36(1):23-30.
    View in: PubMed
    Score: 0.001
  99. Renal artery stenosis and left ventricular hypertrophy: an updated review and meta-analysis of echocardiographic studies. J Hypertens. 2017 12; 35(12):2339-2345.
    View in: PubMed
    Score: 0.001
  100. Association of metabolic syndrome with carotid thickening and plaque in the general population: A meta-analysis. J Clin Hypertens (Greenwich). 2018 01; 20(1):4-10.
    View in: PubMed
    Score: 0.001
  101. Sex-related relationships between uric acid and target organ damage in hypertension. J Clin Hypertens (Greenwich). 2018 01; 20(1):193-200.
    View in: PubMed
    Score: 0.001
  102. Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future. Eur Heart J. 2017 11 21; 38(44):3272-3281.
    View in: PubMed
    Score: 0.001
  103. Personalized medicine-a modern approach for the diagnosis and management of hypertension. Clin Sci (Lond). 2017 Nov 15; 131(22):2671-2685.
    View in: PubMed
    Score: 0.001
  104. Long-term changes in left ventricular mass echocardiographic findings from a general population. J Hypertens. 2017 11; 35(11):2303-2309.
    View in: PubMed
    Score: 0.001
  105. Treatment of hypertension: The ESH/ESC guidelines recommendations. Pharmacol Res. 2018 02; 128:315-321.
    View in: PubMed
    Score: 0.001
  106. The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2017 11; 19(11):1361-1378.
    View in: PubMed
    Score: 0.001
  107. Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up. Blood Press. 2018 02; 27(1):32-40.
    View in: PubMed
    Score: 0.001
  108. Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: a time-integrated analysis. Nephrol Dial Transplant. 2017 Aug 01; 32(8):1351-1356.
    View in: PubMed
    Score: 0.001
  109. Clinical and prognostic significance of a reverse dipping pattern on ambulatory monitoring: An updated review. J Clin Hypertens (Greenwich). 2017 Jul; 19(7):713-721.
    View in: PubMed
    Score: 0.001
  110. Effects of multielectrode renal denervation on elevated sympathetic nerve activity and insulin resistance in metabolic syndrome. J Hypertens. 2017 05; 35(5):1100-1108.
    View in: PubMed
    Score: 0.001
  111. Combined use of short-term and long-term cardiovascular risk scores in primary prevention: an assessment of clinical utility. J Cardiovasc Med (Hagerstown). 2017 May; 18(5):318-324.
    View in: PubMed
    Score: 0.001
  112. Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population. Am J Hypertens. 2017 Mar 01; 30(3):279-285.
    View in: PubMed
    Score: 0.001
  113. Job strain and the incidence of coronary heart diseases: does the association differ among occupational classes? A contribution from a pooled analysis of Northern Italian cohorts. BMJ Open. 2017 01 24; 7(1):e014119.
    View in: PubMed
    Score: 0.001
  114. Neurohumoral and Endothelial Responses to Heated Water-Based Exercise in Resistant Hypertensive Patients. Circ J. 2017 Feb 24; 81(3):339-345.
    View in: PubMed
    Score: 0.001
  115. Prognostic significance of left atrial enlargement in a general population: results of the PAMELA study. Hypertension. 2014 Dec; 64(6):1205-11.
    View in: PubMed
    Score: 0.001
  116. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis. Oncologist. 2012; 17(6):813-22.
    View in: PubMed
    Score: 0.001
  117. Comparison of echotracking and magnetic resonance assessment of abdominal aorta distensibility and relationships with pulse wave velocity. Ultrasound Med Biol. 2011 Dec; 37(12):1970-6.
    View in: PubMed
    Score: 0.001
  118. Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension. J Hypertens. 2009 Aug; 27(8):1672-8.
    View in: PubMed
    Score: 0.001
  119. Cardiac, neuroadrenergic, and portal hemodynamic effects of prolonged aldosterone blockade in postviral child A cirrhosis. Am J Gastroenterol. 2005 May; 100(5):1110-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.